Ads by Google
People with schizophrenia from families with no history of the illness were found to harbor eight times more spontaneous mutations than healthy controls.
Online survey examines overall healthcare in mental health settings from the perspective of both people with schizophrenia and psychiatrists.
A medication that works well for one person with schizophrenia often doesn't work well for another. Genetic variations are thought to play a key role in this difference in response.
Forms of a gene known to increase risk for schizophrenia may create an imbalance in brain pathways for dopamine.
Asenapine, a fast-dissolving, sublingual tablet being developed for treatment of schizophrenia, was more effective than placebo and well tolerated in treating patients with acute schizophrenia.
INVEGA (paliperidone) Extended-Release Tablets showed favorable long-term safety and tolerability in schizophrenia treatment.
Schizophrenia may occur, in part, because of a problem in an intermittent on/off switch for a gene involved in making a key chemical messenger in the brain
Acutely ill, hospitalized patients with schizophrenia showed significant improvement in symptoms after taking INVEGA Extended-Release Tablets as compared to SEROQUEL and placebo.
People with schizophrenia are falling further behind others when it comes to longevity.
TorreyPines Completes Trial Of NGX267 For Treatment Of Cognitive Impairment Associated With Schizophrenia
TorreyPines Therapeutics completed its third Phase I clinical trial for NGX267, in clinical development for the treatment of cognitive impairment associated with schizophrenia (CIAS).